Mild thyroid disorders can cause severe heart problems

Mild thyroid disorders can cause severe heart problems
Types and mechanisms of thyroid hormone signaling. T4 is a prohormone with respect to genomic signaling, but a true fast-acting hormone regarding type 4 action (which is inhibited by the iodothyroacetate TETRAC). Genomic action (type 1, type 2 and mitochondrial signaling) occurs on a slow time scale, whereas non-genomic effects (type 3 and type 4 signaling) represent a fast response (A). Thyroid hormone receptors (THR) usually act as heterodimers. Without thyroid hormone bound they block the transcription together with corepressors. Iodothyronines displace the corepressors and stimulate gene expression together with coactivators (B). Tissue specific distributions of THRs further contribute to the diversity of signaling patterns in the organism (C). AF-1, activation function 1; AF-2, activation function 2; D2, type 2 deiodinase; DBD, DNA-binding domain; HAT, histone acetyl-transferase; HDAc, histone deacetylase; LBD, ligand-binding domain; RXR, retinoid X receptor; TRE, thyroid-hormone response element. Credit: Frontiers in Cardiovascular Medicine (2022). DOI: 10.3389/fcvm.2022.942971

It has been known for more than 200 years that severe thyrotoxicosis may lead to cardiac arrhythmia (irregular heartbeat), one of the major reasons for sudden cardiac death. However, the risk associated with mild hyperthyroidism or hypothyroidism hasn't been understood so far.

A systematic evaluation of 32 studies with 1.3 million participants shows that even slight deviations in can increase the risk of serious cardiovascular diseases.

"This puts our understanding of the interaction between the thyroid gland and the heart on a new footing and might pave the way to personalized preventive care," says associate professor Dr. Johannes Dietrich from the Department of Medicine at St Josef Hospital, Clinic of Ruhr University Bochum, Germany (RUB). The researchers published their work in Frontiers in Cardiovascular Medicine.

For the study, the heart and hormone researchers at RUB collaborated with a clinician scientist/hormone specialist affiliated with Tan Tock Seng Hospital, the Nanyang Technological University's Lee Kong Chian School of Medicine and Duke-NUS Medical School in Singapore.

How should mild thyroid dysfunctions be treated?

Today, overt thyroid dysfunction is recognized as an established risk factor for major adverse cardiovascular events (MACE). However, the situation remained equivocal in mild thyroid dysfunction.

"Whereas in some studies, minimal elevations of thyroid hormones and even high-normal concentrations within the reference range for healthy people predicted an increased risk for , other studies hadn't shown such a correlation," explains Johannes Dietrich. Until very recently, the jury was therefore still out on whether to treat those with subclinical forms of hyperthyroidism and hypothyroidism.

In order to gain a better understanding, a fresh systematic review by the international team analyzed the results of 32 studies on this issue. In a pooled statistical evaluation with consecutive meta-analysis, the researchers found both subclinical hypothyroidism and subclinical hyperthyroidism to predict the risk for cardiovascular mortality. In particular, serum concentrations of the free thyroid hormone T4 (FT4) correlated directly with the probability of cardiac death and other adverse cardiovascular events.

Two different patterns

"The results suggest that cardiovascular risk increases continuously with the FT4 concentration, whereas a complex U-shaped risk relationship exists with the concentration of the controlling thyrotropin, i.e. TSH," elaborates Johannes Dietrich. This dualism may be explained by two different patterns of thyroid-mediated arrhythmia.

In one form ("dyshomeostatic type"), primary thyroid disease directly elevates the concentration of thyroid hormones and thereby increases the cardiovascular risk. In the other form ("allostatic type"), , and psychological strain increase the set point of the regulatory circuit between the and the , so that the indirectly increased FT4 concentration also promote arrhythmia.

"The results of this study might pave the way to a personalized preventive strategy for heart outcomes," conclude the authors. "Moreover, thyroid function might serve as a biomarker for the respective mechanism of origin in patients harboring , helping to tailor individually optimized medication regimen."

More information: Patrick Müller et al, Minor perturbations of thyroid homeostasis and major cardiovascular endpoints—Physiological mechanisms and clinical evidence, Frontiers in Cardiovascular Medicine (2022). DOI: 10.3389/fcvm.2022.942971

Citation: Mild thyroid disorders can cause severe heart problems (2022, October 24) retrieved 23 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Thyroid problems linked to increased risk of dementia


Feedback to editors